AU2017308059A1 - Tissue specific markers for preoperative and intraoperative localization and visualization of tissue - Google Patents

Tissue specific markers for preoperative and intraoperative localization and visualization of tissue Download PDF

Info

Publication number
AU2017308059A1
AU2017308059A1 AU2017308059A AU2017308059A AU2017308059A1 AU 2017308059 A1 AU2017308059 A1 AU 2017308059A1 AU 2017308059 A AU2017308059 A AU 2017308059A AU 2017308059 A AU2017308059 A AU 2017308059A AU 2017308059 A1 AU2017308059 A1 AU 2017308059A1
Authority
AU
Australia
Prior art keywords
tissue
aptamer
seq
specific marker
parathyroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017308059A
Other languages
English (en)
Inventor
James BREDENKAMP
Dennise DALMA-WEISZHAUSZ
Alex Vayser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Invuity Inc
Original Assignee
Invuity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invuity Inc filed Critical Invuity Inc
Publication of AU2017308059A1 publication Critical patent/AU2017308059A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3937—Visible markers
    • A61B2090/395—Visible markers with marking agent for marking skin or other tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4887—Locating particular structures in or on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/335—Modified T or U
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3517—Marker; Tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AU2017308059A 2016-08-12 2017-08-11 Tissue specific markers for preoperative and intraoperative localization and visualization of tissue Abandoned AU2017308059A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662374213P 2016-08-12 2016-08-12
US62/374,213 2016-08-12
US201762528006P 2017-06-30 2017-06-30
US62/528,006 2017-06-30
PCT/US2017/046514 WO2018031894A1 (en) 2016-08-12 2017-08-11 Tissue specific markers for preoperative and intraoperative localization and visualization of tissue

Publications (1)

Publication Number Publication Date
AU2017308059A1 true AU2017308059A1 (en) 2019-02-21

Family

ID=61160616

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017308059A Abandoned AU2017308059A1 (en) 2016-08-12 2017-08-11 Tissue specific markers for preoperative and intraoperative localization and visualization of tissue

Country Status (7)

Country Link
US (2) US20180043037A1 (cg-RX-API-DMAC7.html)
EP (1) EP3497244A4 (cg-RX-API-DMAC7.html)
JP (1) JP2019531706A (cg-RX-API-DMAC7.html)
CN (1) CN109804071A (cg-RX-API-DMAC7.html)
AU (1) AU2017308059A1 (cg-RX-API-DMAC7.html)
CA (1) CA3033188A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018031894A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3414330A4 (en) 2016-02-08 2019-07-03 Vitrisa Therapeutics, Inc. COMPOSITIONS WITH IMPROVED INTRAVITREAL HALF TIME AND USES THEREOF
US10575801B2 (en) 2016-08-11 2020-03-03 Prismatic Sensors Ab Photon counting detector
WO2018148333A1 (en) * 2017-02-08 2018-08-16 Vitrisa Therapeutics, Inc. Compositions with improved intravitreal half-life and uses thereof
JP2020529444A (ja) * 2017-08-09 2020-10-08 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 口腔ケア用途のためのアプタマー
JP2021523454A (ja) 2018-05-17 2021-09-02 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 毛髪分析のためのシステム及び方法
MX2020012225A (es) 2018-05-17 2021-01-29 Procter & Gamble Sistemas y metodos para el analisis de la cobertura del cabello.
HK1257467A2 (zh) * 2018-06-22 2019-10-18 Master Dynamic Limited 癌症细胞检测和成像系统,过程和制品
WO2020005326A1 (en) 2018-06-29 2020-01-02 The Procter & Gamble Company Aptamers for personal care applications
EP3956451A1 (en) 2019-04-16 2022-02-23 The Procter & Gamble Company Aptamers for odor control applications
CN110441242A (zh) * 2019-08-14 2019-11-12 郑州大学 基于金刚石微悬臂梁的气体检测系统和方法
WO2021072289A1 (en) 2019-10-10 2021-04-15 Alume Biosciences, Inc. Methods and systems using peptides for targeting and mapping human nerves in image guided surgery, diagnostics and therapeutic delivery
IT202000014671A1 (it) * 2020-06-18 2021-12-18 Consiglio Nazionale Ricerche Aptameri antitumorali e loro usi
KR20230137930A (ko) * 2021-01-14 2023-10-05 알룸 바이오사이언시스 인코포레이티드 수술 절차에서 요관을 가시화하기 위한 방법 및 조성물
US12488512B2 (en) 2021-04-14 2025-12-02 Cilag Gmbh International Utilizing contextual parameters of one or more surgical devices to predict a frequency interval for displaying surgical information
US12039732B2 (en) 2021-04-14 2024-07-16 The Procter & Gamble Company Digital imaging and learning systems and methods for analyzing pixel data of a scalp region of a users scalp to generate one or more user-specific scalp classifications

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4235157A3 (en) * 2008-07-30 2023-11-22 Vanderbilt University Process and system for intra-operative use of fluorescence and applications of same
CN102458396B (zh) * 2009-04-15 2017-05-10 兰休斯医疗成像公司 使用抗坏血酸稳定化放射性药物组合物
EP2429565A4 (en) * 2009-04-15 2012-11-14 Univ California NEURONIC OR NERVE PEPTIDES AND APTAMERS
US20120055055A1 (en) * 2010-09-02 2012-03-08 Illumin8 Outdoor Media, LLC Systems and Method for Outdoor Media Signage
AU2013361323B2 (en) * 2012-12-19 2018-09-06 Caris Science, Inc. Compositions and methods for aptamer screening
CN103290019B (zh) * 2013-06-14 2014-03-12 严鹏科 一种动脉粥样硬化的靶向适配子及其制备方法和应用
EP3019613B1 (en) * 2013-07-09 2020-03-11 University of Central Lancashire Aptamers against glioma cells
US20150305623A1 (en) * 2014-04-23 2015-10-29 Invuity, Inc. Methods for localizing and treating a parathyroid adenoma
CN105675605A (zh) * 2016-03-29 2016-06-15 中国药科大学 一种利用适配体功能化的金纳米颗粒检测胆汁酸的方法

Also Published As

Publication number Publication date
EP3497244A1 (en) 2019-06-19
CN109804071A (zh) 2019-05-24
JP2019531706A (ja) 2019-11-07
CA3033188A1 (en) 2018-02-15
WO2018031894A1 (en) 2018-02-15
US20210106696A1 (en) 2021-04-15
US20180043037A1 (en) 2018-02-15
EP3497244A4 (en) 2020-04-15

Similar Documents

Publication Publication Date Title
US20210106696A1 (en) Tissue specific markers for preoperative and intraoperative localization and visualization of tissue
US10238757B2 (en) Methods and compositions for detection of cancer
CN107206108B (zh) 术中成像
CA2961095C (en) Upar targeting peptide for use in perioperative optical imaging of invasive cancer
US20080194970A1 (en) Methods for Intraoperative Organotypic Nerve Mapping
Mooney et al. Laser scanning confocal endomicroscopy in the neurosurgical operating room: a review and discussion of future applications
Ma et al. High-precision detection and navigation surgery of colorectal cancer micrometastases
WO2026021204A1 (zh) 一种多功能dna纳米球及其制备方法和应用
JP2018500884A (ja) インビトロおよびインビボにおいてグラム陰性菌を検出するための分子プローブ
Tao et al. Discovery of fatty acid translocase CD36-targeting near-infrared fluorescent probe enables visualization and imaging-guided surgery for glioma
Tansi et al. Endoglin based in vivo near-infrared fluorescence imaging of tumor models in mice using activatable liposomes
Liang et al. Clinical fluorescent probes: mechanisms, advantages and inspirations
Wada et al. Intraoperative near-infrared fluorescence-guided peripheral lung tumor localization in rabbit models
CN103333895B (zh) 一种与人表皮生长因子受体iii型突变体特异性结合的核酸适配子及其应用
JP2023526255A (ja) 可撓性プローブとの組み合わせにおける標的化された蛍光マーカーの使用
WO2014021630A1 (ko) 인테그린αvβ3에 특이적 압타머 및 이의 용도
CN108743975B (zh) 一种靶向肿瘤vegfr-3分子的近红外荧光显像剂的设计、合成及应用
US20120207681A1 (en) Chemical compositions to detect and treat amyloid in a patients brain and retina
JP7581208B2 (ja) 生物製剤標識システムとその方法
US20250302306A1 (en) Tumor targeting probe for image guided surgical methods
Pisano et al. Bladder Cancer
CN110177565A (zh) 胆囊收缩素2受体靶向近红外成像及其用途
JP2025518079A (ja) 腫瘍ナビゲートペプチドによる、miRNAベースの癌の治療方法
CN119055800A (zh) 一种实现前列腺癌术中即刻荧光显影和靶向光热/光动力治疗的一体化探针
KR20250109608A (ko) 악성 흑색종의 진단을 위한 나노 센서 및 이의 용도

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted